Geode Capital Management, LLC Immunovant, Inc. Transaction History

Geode Capital Management, LLC

$1.21 Trillion
Q3 2024

A detailed history of Geode Capital Management, LLC transactions in Immunovant, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 1,510,926 shares of IMVT stock, worth $41.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,510,926

Previous 1,414,002 6.85%

Holding current value

$41.6 Million

Previous $37.3 Million 11.35%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$27.51 - $27.51 $2.67 Million - $2.67 Million	96,924 Added 6.85%	1,510,926 $41.6 Million
Q2 2024 Aug 09, 2024	BUY	$25.1 - $31.61 $2.44 Million - $3.07 Million	97,175 Added 7.38%	1,414,002 $37.3 Million
Q1 2024 May 13, 2024	BUY	$30.27 - $43.79 $1.33 Million - $1.92 Million	43,861 Added 3.45%	1,316,827 $42.5 Million
Q4 2023 Feb 13, 2024	BUY	$31.31 - $44.19 $4.03 Million - $5.68 Million	128,632 Added 11.24%	1,272,966 $53.6 Million
Q3 2023 Nov 13, 2023	SELL	$18.55 - $39.96 $485,805 - $1.05 Million	-26,189 Reduced 2.24%	1,144,334 $43.9 Million
Q2 2023 Aug 11, 2023	BUY	$14.2 - $23.75 $1.73 Million - $2.89 Million	121,805 Added 11.61%	1,170,523 $22.2 Million
Q1 2023 May 15, 2023	BUY	$15.27 - $19.72 $689,028 - $889,825	45,123 Added 4.5%	1,048,718 $16.3 Million
Q4 2022 Feb 13, 2023	BUY	$6.59 - $17.75 $1.25 Million - $3.37 Million	189,926 Added 23.34%	1,003,595 $17.8 Million
Q3 2022 Nov 14, 2022	BUY	$3.93 - $6.37 $73,479 - $119,099	18,697 Added 2.35%	813,669 $4.54 Million
Q2 2022 Aug 12, 2022	BUY	$3.38 - $5.65 $20,732 - $34,657	6,134 Added 0.78%	794,972 $3.1 Million
Q1 2022 May 13, 2022	SELL	$5.06 - $8.77 $159,698 - $276,789	-31,561 Reduced 3.85%	788,838 $4.35 Million
Q4 2021 Feb 11, 2022	SELL	$7.33 - $9.32 $260,280 - $330,943	-35,509 Reduced 4.15%	820,399 $6.99 Million
Q3 2021 Nov 12, 2021	BUY	$7.01 - $11.37 $61,673 - $100,033	8,798 Added 1.04%	855,908 $7.44 Million
Q2 2021 Aug 13, 2021	BUY	$9.4 - $16.85 $486,826 - $872,661	51,790 Added 6.51%	847,110 $8.95 Million
Q1 2021 May 12, 2021	BUY	$13.08 - $49.6 $534,056 - $2.03 Million	40,830 Added 5.41%	795,320 $12.8 Million
Q4 2020 Feb 12, 2021	BUY	$36.36 - $52.71 $7.13 Million - $10.3 Million	196,009 Added 35.1%	754,490 $34.8 Million
Q3 2020 Nov 13, 2020	BUY	$22.61 - $38.9 $4.45 Million - $7.66 Million	196,912 Added 54.46%	558,481 $19.7 Million
Q2 2020 Aug 13, 2020	BUY	$13.87 - $28.44 $4.75 Million - $9.74 Million	342,394 Added 1785.63%	361,569 $8.8 Million
Q1 2020 May 14, 2020	BUY	$8.36 - $17.13 $160,303 - $328,467	19,175 New	19,175 $298,000

Others Institutions Holding IMVT

# of Institutions

211

Shares Held

66.9M

Call Options Held

2.3M

Put Options Held

631K

View Full List

About Immunovant, Inc.

Ticker IMVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 129,077,000
Market Cap $3.55B
Description
Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of mya...

More about IMVT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Immunovant, Inc. Transaction History